Print Print page     Email Email page

Press Releases


MNTA - (NASD) $16.70   + 0.48 Aug 8, 2008 3:00 PM ET
All Releases
View Summary Momenta Pharmaceuticals Announces Results From a Phase 1 Study of M118 Administered as a Subcutaneous Injection
Jul 29, 2008
PDF 18.2 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Results from M118 Drug-Drug Interaction Study with Aspirin and Clopidogrel
Jul 28, 2008
PDF 17.5 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Data Presentations On M118 At Upcoming IXth World Conference On Clinical Pharmacology and Therapeutics Meeting
Jul 25, 2008
PDF 14.3 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Reports Financial Results for the Second Quarter of 2008
Jul 24, 2008
PDF 19.8 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Appoints Bruce A. Leicher as General Counsel
Jul 24, 2008
PDF 14.5 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Second Quarter 2008 Financial Results
Jul 18, 2008
PDF 14.6 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Filing of Abbreviated New Drug Application With a Paragraph IV Certification for Generic Version of Copaxone
Jul 11, 2008
PDF 17.1 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Appointment of James R. Sulat to Board of Directors
Jun 11, 2008
PDF 14.6 KB Add to Briefcase
View Summary Momenta Pharmaceuticals to Present At the Seventh Annual Needham Biotechnology & Medical Technology Conference
May 29, 2008
PDF 14.2 KB Add to Briefcase
View Summary Momenta Pharmaceuticals to Present At 2008 Citi Investment Research Global Healthcare Conference
May 15, 2008
PDF 14.2 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Date for 2008 Annual Meeting of Stockholders
May 15, 2008
PDF 13.9 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Reports Financial Results for the First Quarter of 2008
May 7, 2008
PDF 20.8 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for First Quarter 2008 Financial Results
May 1, 2008
PDF 14.6 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Receives Regulatory Guidance On M-Enoxaparin ANDA
Apr 29, 2008
PDF 16.3 KB Add to Briefcase
View Summary Momenta Pharmaceuticals to Present At Deutsche Bank 33rd Annual Health Care Conference
Apr 28, 2008
PDF 14.2 KB Add to Briefcase
View Summary Momenta Pharmaceuticals to Present At 2008 Morgan Stanley Global Healthcare Unplugged Conference
Apr 23, 2008
PDF 14.3 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Announces Presentation of M118 Phase 1 Results At the American Society for Clinical Pharmacology and Therapeutics Annual Meeting
Apr 4, 2008
PDF 18.9 KB Add to Briefcase
View Summary Momenta Pharmaceuticals to Present At Cowen and Company 28th Annual Health Care Conference
Mar 11, 2008
PDF 14.2 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Appoints Dr. James M. Roach as Chief Medical Officer
Mar 4, 2008
PDF 14.9 KB Add to Briefcase
View Summary Momenta Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year End 2007
Feb 14, 2008
PDF 22.4 KB Add to Briefcase
Showing 1-20 of 137 Page: 1 2 3 ... 7  Next 20
= add release to Briefcase
Quotes delayed at least 20 minutes. Information provided by TurboFeed.